| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/18/1996 | WO1996001429A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | WO1996001425A2 Assay for inhibitors of dp-1 and other dp proteins |
| 01/18/1996 | WO1996001322A1 Serum paraoxonase |
| 01/18/1996 | WO1996001321A1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 01/18/1996 | WO1996001319A1 Variants of leukemia inhibitory factor |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001317A2 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001315A1 Antisense sequence and ribozyme expression cassette |
| 01/18/1996 | WO1996001313A1 Tetracycline-regulated transcriptional modulators |
| 01/18/1996 | WO1996001277A1 METHOD FOR IMMUNOASSAYING SOLUBLE Fas ANTIGEN AND KIT THEREFOR |
| 01/18/1996 | WO1996001276A1 Expression of a functional human type i interferon receptor |
| 01/18/1996 | WO1996001275A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | WO1996001274A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 01/18/1996 | WO1996001273A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | WO1996001272A1 Helicobacter proteins and vaccines |
| 01/18/1996 | WO1996001271A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | WO1996001122A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | WO1996001116A1 Chicken infectious anemia virus vaccine |
| 01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
| 01/18/1996 | WO1995034320A3 Methods for inhibiting antigen specific t cell responses |
| 01/18/1996 | DE4425778A1 Komplexverbindungen zur Diagnose von Gefäßerkrankungen Complexes for the diagnosis of vascular disease |
| 01/18/1996 | DE4424577A1 Transporter protein for cationic xenobiotic(s) and pharmaceuticals, and related DNA and transformed cells |
| 01/18/1996 | CA2194396A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | CA2194390A1 Serum paraoxonase |
| 01/18/1996 | CA2194239A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | CA2194237A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | CA2194169A1 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
| 01/18/1996 | CA2193685A1 Screening for nuc inhibitors |
| 01/18/1996 | CA2193399A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | CA2193091A1 Assay for inhibitors of dp-1 and other dp proteins |
| 01/18/1996 | CA2192565A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/17/1996 | EP0692537A2 Recombinant gibberellin DNA and uses thereof |
| 01/17/1996 | EP0692536A2 IFN-Y production inducing protein and monoclonal antibody of the same |
| 01/17/1996 | EP0692534A2 A chromosome integration vector |
| 01/17/1996 | EP0692532A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof |
| 01/17/1996 | EP0692490A2 Recombinant Alzheimer's amyloid protein protease inhibitor |
| 01/17/1996 | EP0692489A1 Preparation of stable zinc insulin analog crystals |
| 01/17/1996 | EP0692488A2 Interleukin 4 signal transducers and binding assays |
| 01/17/1996 | EP0692032A1 Suppressor of hiv replication and transcription |
| 01/17/1996 | EP0692031A1 Heterologous antigens in live cell vaccine strains |
| 01/17/1996 | EP0692030A1 Control of plant abscission and pod dehiscence |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 01/17/1996 | EP0692028A1 Pharmaceuticals based on papillomaviruses |
| 01/17/1996 | EP0692027A1 Expression of beta-2-microglobulin in pichia pastoris |
| 01/17/1996 | EP0692026A1 A human t-cell receptor of the g-protein coupled receptor family |
| 01/17/1996 | EP0692025A1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 01/17/1996 | EP0691989A1 Biologically active polypeptide fusion dimers |
| 01/17/1996 | EP0691988A1 Inhibitor of stem cell proliferation and uses thereof |
| 01/17/1996 | EP0691987A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 01/17/1996 | EP0691986A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS |
| 01/17/1996 | EP0691984A1 Purification of factor vii |
| 01/17/1996 | EP0691982A1 Separation of proteins |
| 01/17/1996 | EP0691851A1 A method to produce a substance to inhibit cell penetration, and a contraceptive to prevent conception, and a thrombus, prostate and aids vaccine and medicine |
| 01/17/1996 | EP0691828A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage |
| 01/17/1996 | EP0461193B1 Discrimination between antibodies against htlv-i, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits |
| 01/17/1996 | EP0436526B1 Use of antibodies to angiogenin: immunotherapeutic agents |
| 01/17/1996 | EP0314705B1 A novel family of primate hematopoietic growth factors |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/16/1996 | US5484956 Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
| 01/16/1996 | US5484905 Isolated dna fragment |
| 01/16/1996 | US5484892 Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells |
| 01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
| 01/16/1996 | US5484890 Antihemophilic factor stabilization |
| 01/16/1996 | US5484889 Plant protein useful for treating tumors and HIV infection |
| 01/16/1996 | US5484887 Homogeneous interleukin 1 |
| 01/16/1996 | US5484886 Human neurokinin-1 receptor |
| 01/16/1996 | US5484885 Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37 |
| 01/16/1996 | US5484773 Treatment of antibiotic associated diarrhea |
| 01/16/1996 | US5484770 Peptide compounds which inhibit the proliferation of epidermal or epithelial stem cells |
| 01/16/1996 | US5484767 Substantially pure steroidogenesis inducing protein and uses thereof |
| 01/16/1996 | US5484732 Transcription factor for regulation of the development of skin and hair |
| 01/16/1996 | US5484728 Parathion hydrolase analogs and methods for production and purification |
| 01/16/1996 | US5484722 Biopolymer and effector substance conjugates, process for the preparation thereof and their use |
| 01/16/1996 | US5484719 Vaccines produced and administered through edible plants |
| 01/16/1996 | US5484718 Genetic engineering |
| 01/16/1996 | US5484711 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
| 01/16/1996 | US5484710 Gene expression |
| 01/16/1996 | US5484591 Method for treating gram negative bacterial infections in humans |
| 01/16/1996 | CA1337935C Antibiotic derived from bacillus subtilis strains ncib 12375, 12376 and 12616 and related strains |
| 01/16/1996 | CA1337932C Affinity membranes having pendant hydroxy groups and processes for the preparation and use thereof |
| 01/14/1996 | CA2153720A1 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 01/11/1996 | WO1996000791A1 Recombinant infectious laryngotracheitis virus and vaccine |
| 01/11/1996 | WO1996000784A1 Nucleic acid fragments and corresponding peptide fragments from the caprine arthritis-encephalitis virus (caev) genome, and uses thereof |
| 01/11/1996 | WO1996000783A1 Antibodies which bind to insect gut proteins and their use |
| 01/11/1996 | WO1996000782A1 Stem cell immobilisation |
| 01/11/1996 | WO1996000739A1 Modified g-protein coupled receptors |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000737A1 Cytokines supporting progenitor proliferation, progenitor differentiation or platelet formation |
| 01/11/1996 | WO1996000587A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | WO1996000586A2 Methods for treating cell proliferative disorders by modulating signal transduction |
| 01/11/1996 | WO1996000583A1 Polynucleotide vaccine for papillomavirus |
| 01/11/1996 | WO1996000581A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | WO1996000577A1 Agents affecting thrombosis hemostasis |
| 01/11/1996 | WO1996000503A1 Novel peptides |
| 01/11/1996 | WO1996000502A1 Bacillus thuringiensis isolates active against cockroaches |
| 01/11/1996 | WO1995034634A3 Use of anthocyanin genes to maintain male sterile plants |